Fengyuan Pharmaceutical: Notice on the Company\'s Shareholders\' Agreed Repurchase Securities Transactions
Fengyuan Pharmaceutical: Notice on Shareholders\' Agreed Repurchase Securities Transactions Due to Expiry and Repurchase
Fengyuan Pharmaceutical: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
Fengyuan Pharmaceutical: Notice on Repurchase and Cancellation of Some Restricted Stock Capital Reduction and Notice to Creditors
Fengyuan Pharmaceutical: Legal Opinion of Fengyuan Pharmaceutical\'s 2024 Second Extraordinary General Meeting of Shareholders
Fengyuan Pharmaceutical: Notice on Convening the Company\'s Second Extraordinary General Meeting of Shareholders in 2024
Fengyuan Pharmaceutical: Announcement on the progress of joint investment in industrial funds with professional investment institutions
Fengyuan Pharmaceutical: 2024 Semi-Annual Financial Report
Fengyuan Pharmaceutical: Semi-annual Non-Operating Capital Occupancy and Other Related Capital Transactions Summary
Anhui Fengyuan Pharmaceutical: Board of Directors Rules of Procedure (Revised May 2024)
Anhui Fengyuan Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Anhui Fengyuan Pharmaceutical: Articles of Association (revised in May 2024)
Anhui Fengyuan Pharmaceutical: 2023 Annual General Meeting of Shareholders Legal Opinions
Anhui Fengyuan Pharmaceutical: Internal Control Self-Assessment Report
Anhui Fengyuan Pharmaceutical: Announcement on providing guarantees for working capital loans for wholly-owned subsidiaries
Anhui Fengyuan Pharmaceutical: 2023 Annual Financial Report
Anhui Fengyuan Pharmaceutical: Announcement on preparation for impairment in 2023
Anhui Fengyuan Pharmaceutical: Fengyuan Pharmaceutical 2023 Financial Results Report
Anhui Fengyuan Pharmaceutical: Working system for special meetings of independent directors
Anhui Fengyuan Pharmaceutical: Notice of Annual General Meeting of Shareholders
No Data